MARIMED INC.

corporate_fare Company Profile

MARIMED INC.

Exchange: OTCSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed MRMD - Latest Insights

Filing Type

Date Range

MRMD

Apr 23, 2026, 4:06 PM EDT

Filing Type: DEF 14A

Importance Score:

8

MariMed Proxy Details Extensive Related-Party Transactions and CEO Guarantees Amidst Financial Distress

Sentiment: Negative

View Wiseek Article

MRMD

Mar 12, 2026, 4:08 PM EDT

Filing Type: 10-K

Importance Score:

8

MariMed Reports Increased Net Loss, $7.3M in IRS Tax Liens, and Debt Restructuring in 2025 Annual Report

Sentiment: Negative

View Wiseek Article

MRMD

Mar 11, 2026, 5:05 PM EDT

Source: GlobeNewswire

Importance Score:

8

MariMed Reports Modest Revenue Growth, Sixth Year of Positive Adjusted EBITDA in FY25

Sentiment: Neutral

View Wiseek Article

MRMD

Mar 02, 2026, 4:15 PM EST

Source: GlobeNewswire

Importance Score:

8

MariMed Extends $14.7M Preferred Stock Obligation to 2031, Significantly Reducing Refinancing Risk

Sentiment: Positive

View Wiseek Article

MRMD

Mar 02, 2026, 4:03 PM EST

Filing Type: 8-K

Importance Score:

8

MariMed Restructures $14.2M Obligation, Issues $8M in New Notes and Convertible Preferred Stock

Sentiment: Positive

View Wiseek Article